Markus F Renschler

Title: Innovations of Markus F Renschler

Introduction

Markus F Renschler is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for treating lymphoproliferative disorders. His innovative work has led to the creation of a patent that addresses critical medical challenges.

Latest Patents

Markus F Renschler holds a patent for "Receptor-binding antiproliferative peptides." This patent outlines methods and compositions for identifying antiproliferative polypeptides that inhibit clonal expansion and induce apoptosis in specific cell populations. The invention focuses on cells expressing a cell surface receptor from the immunoglobulin superfamily. By isolating a predetermined cell population from patients, such as through lymph node biopsies or blood samples, the identified peptides can be utilized as therapeutic agents in anti-idiotype therapy for lymphoproliferative disorders. He has 1 patent to his name.

Career Highlights

Throughout his career, Markus has demonstrated a commitment to advancing medical science through his innovative research. His work has not only contributed to the understanding of cell behavior but also provided potential therapeutic avenues for treating serious health conditions.

Collaborations

Markus has collaborated with esteemed colleagues in his field, including Ronald Levy and Ramesh R Bhatt. These partnerships have enhanced the impact of his research and broadened the scope of his innovations.

Conclusion

Markus F Renschler's contributions to biotechnology through his patented innovations exemplify the importance of research in developing new therapeutic strategies. His work continues to inspire advancements in the treatment of lymphoproliferative disorders.